New Treatment Approach Using Peptoid‐Based Vaccines in Parkinson's Disease
Fuente:
Wiley Open Access
Saved in:
| Main Authors: | Seyedeh Toktam Ekrani, Tola Abdulsattar Faraj, Chnar Husam Taha, Seyed‐Alireza Esmaeili |
|---|---|
| Format: | Artículo Open Access |
| Published: |
Wiley
2026
|
| Subjects: | |
| Online Access: | |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
Targeting Alpha‐Synuclein Aggregation With Chemical Chaperone IP‐045: An Approach to Parkinson's Disease Therapy
by: Navpreet Kaur, et al.
Published: (2026)
by: Navpreet Kaur, et al.
Published: (2026)
Recent Development in Celiac Disease: Pathophysiology, Animal Models and Treatments
by: Vishal Patel, et al.
Published: (2025)
by: Vishal Patel, et al.
Published: (2025)
Cellular and molecular mechanisms involved in the analgesic effects of botulinum neurotoxin: A literature review
by: Saereh Hosseindoost, et al.
Published: (2024)
by: Saereh Hosseindoost, et al.
Published: (2024)
Mesalamine in Treatment of Intestinal Inflammatory Diseases—Formulation‐Driven Strategies for Targeted Colonic Therapy and Remission Maintenance
by: Bijayananda Sahoo, et al.
Published: (2026)
by: Bijayananda Sahoo, et al.
Published: (2026)
Orthoallosteric EGFR‐TKIs: A New Paradigm in NSCLC Treatment Strategy Targeting the C797S Mutation
by: Iqrar Ahmad, et al.
Published: (2024)
by: Iqrar Ahmad, et al.
Published: (2024)
Leveraging the Fragment Merging Approach for Synthetizing Novel Selanyl Phenyl Acetamide Thiazolidinedione Hybrids Endowed With Apoptotic Potential for Cancer Treatment
by: Saad Shaaban, et al.
Published: (2025)
by: Saad Shaaban, et al.
Published: (2025)
Design, Green Synthesis, and Biological Evaluation of Novel Triaryl‐Tethered Acryloyl Derivatives as New Generation β‐Tubulin Inhibitors for Hepatocellular Carcinoma Treatment
by: Aamal A. Al‐Mutairi, et al.
Published: (2026)
by: Aamal A. Al‐Mutairi, et al.
Published: (2026)
Discovery of Novel 5‐Substituted‐4‐Allyl‐1,2,4‐Triazoles as Potential Nonsteroidal Anti‐Inflammatory Agents via Downregulation of iNOS Expression
by: Samar H. Abbas, et al.
Published: (2026)
by: Samar H. Abbas, et al.
Published: (2026)
Rational Design and Characterization of 5‐Fluorouracil–Loaded Lipid–Polymer Hybrid Nanoparticles for Enhanced Transdermal Delivery in Skin Cancer Therapy
by: Tenzin Sonam Dongsar, et al.
Published: (2026)
by: Tenzin Sonam Dongsar, et al.
Published: (2026)
Design, Synthesis, In Vitro and In Vivo Biological Evaluation of Novel Pyrazolo[3,4‐ d ]Pyrimidine‐Based Derivatives as Promising Multitarget Candidates for Alzheimer's Disease
by: Mohamed T. M. Nemr, et al.
Published: (2026)
by: Mohamed T. M. Nemr, et al.
Published: (2026)
Chitosan‐coated nanoparticles in innovative cancer bio‐medicine
by: Niloufar Rezaei, et al.
Published: (2024)
by: Niloufar Rezaei, et al.
Published: (2024)
Optimizing Treatment: The Role of Pharmacology, Genomics, and AI in Improving Patient Outcomes
by: Fazil Ahmad
Published: (2025)
by: Fazil Ahmad
Published: (2025)
Management of Alzheimer's Disease With Nanotechnological Interventions and Novel Therapeutics
by: Mohd Shahrukh, et al.
Published: (2025)
by: Mohd Shahrukh, et al.
Published: (2025)
Design, Synthesis, Biological Evaluation and Molecular Docking Study of New 1,3,4‐Thiadiazole‐Based Compounds as EGFR Inhibitors
by: Marwa I. Serag, et al.
Published: (2024)
by: Marwa I. Serag, et al.
Published: (2024)
Protective effect of thymoquinone nanoemulsion in reducing the cardiotoxic effect of 5‐fluorouracil in rats
by: Bardia Karim, et al.
Published: (2024)
by: Bardia Karim, et al.
Published: (2024)
Targeting mTOR Kinase for Cancer Treatment: A Comprehensive Review With Clinical Insights
by: Md. Takdir Hossain, et al.
Published: (2025)
by: Md. Takdir Hossain, et al.
Published: (2025)
Sirtuin 1 Is a Potential Target for the Treatment of Neurogenic Intermittent Claudication by Modulating Pyroptosis
by: Xuejian Dan, et al.
Published: (2025)
by: Xuejian Dan, et al.
Published: (2025)
Innovative Drug and Prodrug Candidates in Cancer Treatment Targeting TP53 Mutations: Challenge and Hope
by: Raed M. Al‐Zoubi, et al.
Published: (2026)
by: Raed M. Al‐Zoubi, et al.
Published: (2026)
Design and Discovery of New Dual Carbonic Anhydrase IX and VEGFR‐2 Inhibitors Based on the Benzenesulfonamide‐Bearing 4‐Thiazolidinones/2,4‐Thiazolidinediones Scaffold
by: Merve Zengin, et al.
Published: (2024)
by: Merve Zengin, et al.
Published: (2024)
Design and Development of PLGA‐PEG‐FA Nanoparticles Encapsulating Noscapinoids for Receptor‐Mediated Breast Cancer Treatment
by: Namita Bhoi, et al.
Published: (2026)
by: Namita Bhoi, et al.
Published: (2026)
A Decade of Mitochondria‐Targeting Drugs in Cancer Treatment: Case Review on Mitochondria‐Targeting Curcumin or Mitocurcumin
by: Rahul Shah, et al.
Published: (2025)
by: Rahul Shah, et al.
Published: (2025)
Design, Synthesis, and Biological Evaluation of Potent FLT3 Inhibitor for Acute Myeloid Leukemia (AML) Treatment
by: Kun Du, et al.
Published: (2025)
by: Kun Du, et al.
Published: (2025)
Mitochondrial Dysfunction in Inflammatory Skin Diseases: Mechanisms, Biomarkers, and Emerging Therapeutic Strategies
by: Mei Li, et al.
Published: (2026)
by: Mei Li, et al.
Published: (2026)
Rational Discovery of BACE1‐Selective Inhibitors as Potential Therapeutics for Alzheimer's Disease
by: Tanmaykumar Varma, et al.
Published: (2025)
by: Tanmaykumar Varma, et al.
Published: (2025)
Role of BIX01294 in the intracranial inhibition of H3K9 methylation lessens neuronal loss in vascular dementia model
by: Fardin Sehati, et al.
Published: (2024)
by: Fardin Sehati, et al.
Published: (2024)
Design, Synthesis, and Biological Activities Evaluation of Type I FLT3 Inhibitors for the Treatment of Acute Myeloid Leukemia
by: Jin Yang, et al.
Published: (2024)
by: Jin Yang, et al.
Published: (2024)
New Chlorophenyl Dioxo‐Imidazolidines for Bacterial Biofilm
by: Shanmugha Samy, et al.
Published: (2025)
by: Shanmugha Samy, et al.
Published: (2025)
Targeting the NLRP3 Inflammasome: Novel Inhibitors for Cardiovascular Diseases Management — A Narrative Review
by: Yomna S. Momen
Published: (2026)
by: Yomna S. Momen
Published: (2026)
A Novel Oxo‐Palmatine Derivative 2q as Potent Reversal Agents Against Alzheimer's Disease
by: Shuo Pang, et al.
Published: (2025)
by: Shuo Pang, et al.
Published: (2025)
Space Pharmaceutical Manufacturing: Emergence of a New Era for Pharmaceutical Industry
by: Manali Patel, et al.
Published: (2025)
by: Manali Patel, et al.
Published: (2025)
Reduced Taurine Transporter Expression in Lymphoblastoid Cell Lines From Alzheimer's Disease Patients Compared With Age‐Matched Controls: Therapeutic Implications?
by: Yuval Gavriel, et al.
Published: (2025)
by: Yuval Gavriel, et al.
Published: (2025)
Rational Design of Triazole Hydrazide Derivatives With Imidazo[2,1‐ b ]thiazole Scaffolds as Targeted EGFR Inhibitors in NSCLC
by: Mohamed K. Elgohary, et al.
Published: (2025)
by: Mohamed K. Elgohary, et al.
Published: (2025)
From Sulfa Drugs to New Antibacterial Agents: Advances in Chemical Modification of Approved Sulfonamides
by: Ayşe Karagüzel, et al.
Published: (2025)
by: Ayşe Karagüzel, et al.
Published: (2025)
Design, Synthesis, and 2D QSAR Analysis of Some Novel Pyrazolo[1,5‐a]pyrimidine Derivatives as Pim‐1 Kinase Inhibitors for the Treatment of MCF‐7 Breast Cancer
by: Esraa Z. Mohammed, et al.
Published: (2025)
by: Esraa Z. Mohammed, et al.
Published: (2025)
From Cancer to Neuroprotection: Pazopanib Modulates the RIPK1/RIPK3/MLKL and PGAM5/DRP1 Pathways in 3‐ Nitropropionic Acid‐Induced Huntington's Disease
by: Muhammad A. Eltarzy, et al.
Published: (2026)
by: Muhammad A. Eltarzy, et al.
Published: (2026)
Study on the Mechanism of Aspirin Alleviating Kawasaki Disease With Coronary Artery Lesions by Inducing TRAF6 to Regulate STAT3 Ubiquitination and Inhibit Th17 Cell Differentiation
by: Xiangzhen Qu, et al.
Published: (2025)
by: Xiangzhen Qu, et al.
Published: (2025)
Imidazolidine‐Based Aspartate Inhibitors for Candida Infections
by: B. Bindu, et al.
Published: (2025)
by: B. Bindu, et al.
Published: (2025)
Repurposing Nitroimidazoles: A New Frontier in Combatting Bacterial Virulence and Quorum Sensing via In Silico, In Vitro, and In Vivo Insights
by: El‐Sayed Khafagy, et al.
Published: (2025)
by: El‐Sayed Khafagy, et al.
Published: (2025)
Unlocking the Anticancer Potential of New Spirooxindoles via p53‐MDM2/MDMX Dual Inhibition: In Vitro and In Silico Assessments
by: Haidy H. El‐Zoheiry, et al.
Published: (2026)
by: Haidy H. El‐Zoheiry, et al.
Published: (2026)
New Ester‐Containing Azole Derivatives With Potent Anti‐Candida Effects: Synthesis, Antifungal Susceptibility, Cytotoxicity, and Molecular Modeling Studies
by: Yusuf Ataker, et al.
Published: (2024)
by: Yusuf Ataker, et al.
Published: (2024)
Similar Items
-
Targeting Alpha‐Synuclein Aggregation With Chemical Chaperone IP‐045: An Approach to Parkinson's Disease Therapy
by: Navpreet Kaur, et al.
Published: (2026) -
Recent Development in Celiac Disease: Pathophysiology, Animal Models and Treatments
by: Vishal Patel, et al.
Published: (2025) -
Cellular and molecular mechanisms involved in the analgesic effects of botulinum neurotoxin: A literature review
by: Saereh Hosseindoost, et al.
Published: (2024) -
Mesalamine in Treatment of Intestinal Inflammatory Diseases—Formulation‐Driven Strategies for Targeted Colonic Therapy and Remission Maintenance
by: Bijayananda Sahoo, et al.
Published: (2026) -
Orthoallosteric EGFR‐TKIs: A New Paradigm in NSCLC Treatment Strategy Targeting the C797S Mutation
by: Iqrar Ahmad, et al.
Published: (2024)